Navigation Links
Nanotech in your vitamins
Date:1/14/2009

The ability of the Food and Drug Administration (FDA) to regulate the safety of dietary supplements using nanomaterials is severely limited by lack of information, lack of resources and the agency's lack of statutory authority in certain critical areas, according to a new expert report released by the Project on Emerging Nanotechnologies (PEN).

The report, A Hard Pill To Swallow: Barriers to Effective FDA Regulation of Nanotechnology-Based Dietary Supplements, details the main problems at FDA in regulating nano-enabled dietary supplements and offers a host of recommendations for improving oversight of such products.

"Historically, the regulation of dietary supplements has been a significant challenge for FDA, and the fact that some of those products are now being manufactured using nanotechnology creates an additional layer of complexity," says William B. Schultz, a co-author of the report and a former FDA official.

Little is known about the use of engineered nanoparticles in the dietary supplement market. Current law requires supplement manufacturers to disclose limited information about their products, and what information is available is a result of dietary supplement manufacturers touting the use of nanotechnology when marketing their products, according to the report.

"While it is not possible to precisely determine the prevalence of dietary supplements using engineered nanoparticles, it is likely that the public's exposure to these products will grow significantly in the next several years," says Lisa Barclay, also a co-author of the report.

According to an inventory of federal environmental, health and safety research on nanotechnology maintained by PEN, the U.S. government is spending less than $1 million annually to study the direct impact of nanoscale materials on the gastrointestinal tract.

"It is not clear that the supplement industry is conducting the rigorous testing needed either to understand the effects of nan
'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy
2. Nanotechnology Causes Disruption - Cross Industry
3. Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance
4. Small is beautiful: A European view of nanotech cosmetics and safety
5. Astute Nanotechnology celebrates first year of success
6. New nanotech products hitting the market at the rate of 3-4 per week
7. Improved Governance Needed To Realize Nanotechs Benefits
8. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
9. Breakthroughs in nanotechnology on edge of knowledge frontier
10. Federal toxics disclosure law could help inform public of nanotechnology risks
11. Cleaner water through nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Diabetes currently has no cure. According to an ... made several breakthroughs in search for a ... indicates that cure for diabetes is still many years ... forward-thinking entrepreneurs and health professionals who made strides in ... Kenneth Pullman is one of the individuals with genuine ...
(Date:9/17/2014)... 2014 Skin management experts™ at ... of the first in the USA to introduce a ... to minimize the appearance of vertical chest lines and ... with the first FDA-cleared ultrasound based facial procedure to ... have expanded their brand into tightening and smoothing the ...
(Date:9/17/2014)... AURORA, Colo. (PRWEB) September 17, 2014 ... American Sentinel University offers tips to health IT professionals ... , A recent study by HIMSS shows demand ... high and a candidate’s skill set is the differentiating ... is that of an IT professional that has clinical ...
(Date:9/17/2014)... 2014 Lee Berman, a seasoned veteran ... appearing on The Balancing Act® airing on Lifetime Television®. ... The segment will premiere on September 19 and re-air ... airing on Lifetime Television®' with show host Julie Moran. ... for over a decade and is the Director of ...
(Date:9/17/2014)... Kingston, NY (PRWEB) September 17, 2014 ... style of wellness to the lineup at Techmanity, a ... as “the next generation of tech events,” Techmanity will ... Voom is excited to join the ranks of Cisco, ... this first ever Silicon Valley Technology Conference. , Voom ...
Breaking Medicine News(10 mins):Health News:Discover a Safe and Effective Treatment for Diabetes with The Diabetes Protocol – Vinamy 2Health News:FACE Skincare Medical Wellness Debuts Ultherapy Décolletage Treatment 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Lee Berman Will Appear On The Balancing Act® airing on Lifetime Television® 2Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2
... DENVER, July 31 Birner Dental Management,Services, Inc. ... dental practices,will conduct a conference call to review ... results, the teleconference may include,discussion of management,s expectations ... be held on Thursday, August 14, 2008 at ...
... 9% Increase In Revenues - - Florida Upholds Contract Award To Orchid ... ... - Regional Tender Work Underway In U.K. -, PRINCETON, N.J., ... identity DNA testing,services, today reported its financial results for the second quarter of,2008., ...
... Fla., July 31 NeoGenomics, Inc.,(OTC Bulletin Board: NGNM) today ... during the quarter included,the following:, Second Quarter 2008 ... 07 -- 17% sequential increase in revenue vs. Q1 ... initiative -- Average number of tests/requisition ...
... safety services, gained four new contracts in the second quarter, including ... awarded a significant contract expansion. , ... Little Falls, ... http://www.sentrx.com/drug_safety_services.shtml [drug safety __title__ drug safety] services, announced today ...
... QHR hospital client King,s Daughters Medical Center (KDMC) in ... grant as a part of the 2009 Health and ... by the Senate Appropriations Committee earlier this month. KDMC,s ... Wicker (Miss.), was initiated by QHR and its strategic ...
... The bestselling guide is now filled with new, essential information for knowing ... treatable disease. , ... Hoboken, NJ (PRWEB) July 31, 2008 -- Ever ... the book has been a major resource for those with diabetes and ...
Cached Medicine News:Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 2Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 3Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 4Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 5Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 6Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 7Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 8Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 9Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 2Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 3Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 4Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 5Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 6Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 7Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 8Health News:Sentrx Growth Continues with Four New Clients in Second Quarter 2Health News:Sentrx Growth Continues with Four New Clients in Second Quarter 3Health News:Healthcare Consulting Leader QHR, Strategic Health Care, Sen. Roger Wicker Partnership Yields $500,000 Grant for King's Daughters Medical Center 2Health News:Healthcare Consulting Leader QHR, Strategic Health Care, Sen. Roger Wicker Partnership Yields $500,000 Grant for King's Daughters Medical Center 3Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 2Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 3Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 4
(Date:9/16/2014)... 3SBio Inc., ("3SBio") a leading biotechnology ... focusing on researching, developing, manufacturing and marketing biopharmaceutical ... an exclusive license agreement with JenKem Technology Co., ... in Mainland China of PEG-irinotecan, a long-acting polymer-drug ... over-expressed in many solid tumors, including colorectal, ovarian, ...
(Date:9/16/2014)... OAKLAND, Calif. , Sept. 16, 2014  Chairman ... that Richard (Dick) Daniels will assume the ... Foundation Hospitals and Health Plan, Inc., effective immediately. ... developing and implementing technological advancements that advance the high-quality ... members," Tyson said. " Dick Daniels has extensive ...
(Date:9/16/2014)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) ... all of the outstanding shares of Auxilium Pharmaceuticals, Inc. (NASDAQ: ... $28.10 in a cash and stock transaction valued at $2.2 ... to Auxilium,s closing price on September 16, 2014 and a ... for the previous 30 days.  Under the terms of the ...
Breaking Medicine Technology:3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Name Interim Chief Information Officer 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 3Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 4Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 5Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 6Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 7
... KineMed Inc., a,pathway-based drug discovery and development ... of an investigational agent,to regenerate nerve cells in ... cognition and mood. The agent, part of a ... a behavioral test in a,preclinical model. The findings ...
... am ET, BEDMINSTER, N.J., Oct. 11 ... top-line results from,the company,s Phase 3 study of ... 83 patients with short bowel,syndrome (SBS) received either ... dose (0.10 mg/kg/day) or placebo. The,clinical efficacy endpoint ...
Cached Medicine Technology:KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 2Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 5Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 6Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 7
... These offer truly exceptional quality for this ... aberration has been dramatically improved with performance ... These objectives are also corrected for spherical ... entire 22mm field of view. The DL ...
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark...
... Designed for the scientist who wants ... the TE2000E2 is a high precision Z-focus ... This makes it possible to expand ... sources and image outputs. A five-way ...
... The IX71's modular ... provides 9 access ports ... output devices. Up to ... simultaneous access to a ...
Medicine Products: